Jin, R., Haughton, J. M., Goddard, E. J., Courmier, D., Radziszewski, W., Meadows, R. H., . . . Cohen, S. (2025, March). Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme. Rheumatology and Therapy.
芝加哥风格引文Jin, Ran, James M. Haughton, Emily J. Goddard, Delphine Courmier, Waldemar Radziszewski, Rachael H. Meadows, James Piercy, 与 Stanley Cohen. "Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme." Rheumatology and Therapy Mar. 2025.
MLA引文Jin, Ran, et al. "Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme." Rheumatology and Therapy, Mar. 2025.